Study suggests dapivirine vaginal ring is safe to use as HIV prevention during breastfeeding

A monthly vaginal ring containing the antiretroviral drug dapivirine—an HIV prevention method that has been approved in several African countries and recommended by the World Health Organization (WHO) –appears to be safe when used during breastfeeding, suggest results of a Phase IIIb open-label study presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2023) in Seattle.